November 2022:

SERICHIM is working together with ICGEB in Trieste on biopharmaceutical development. Have a look at this recent video to know more about our projects.
This story recounts how our scientific research can improve healthcare and therapies.


May 2022:

Certiquality confirms that SERICHIM has implemented and maintains a quality management system that complies with the standard UNI EN ISO 9001:2015 extending the Certification also to the new Biotechnology sector. (PDF)


May 2021:

Biovalley Investments Partner SpA (BIP SpA) acquires the shares of Aqisitio Srl and fully subscribes the capital increase to € 652,500 consolidating the control of the company. BIP SpA, which in the first months of 2021 successfully completed a capital increase from € 7.681.111 to € 11.058.593, in this way confirms its commitment to support Serichim's development projects in the biotechnology sector and the production of Active Pharmaceutical Ingredients.



February 2020:

SERICHIM S.r.l. take part to BioHighTech NET 4.0, the main business network in Friuli Venezia Giulia in biomed, biotech and bioinformatics. 

(PDF allegato)



January 2019

SERICHIM S.r.l. approves a capital increase dedicated to Biovalley Investments Partner S.r.l.(BIP) wich then hold the absolute majority of shares of the company. The Board of Directors is renewed with the entry of three new directors appointed by BIP.


SERICHIM S.r.l. - Piazzale Marinotti 1 - 33050 Torviscosa (UD) - Italy
Tel. +39 0431 381403 - Fax +39 0431 381400 -
P. IVA 02390250302 - Privacy Policy - Cookie Policy